The Effects of Tacrolimus and Erythropoietin on Histopathologic and Functional Recovery of Sciatic Nerve Crush in Mice
Author:
Mansouri Kimia1, Fattahian Hamidreza1, Jahandideh Alireza1, Akbarein Hesameddin2
Affiliation:
1. 1 Department of Clinical Sciences, Science and Research Branch , Islamic Azad University , Tehran , Iran 2. 2 Department of Food Hygiene and Quality Control, Faculty of Veterinary Medicine , University of Tehran , Tehran , Iran
Abstract
Abstract
Currently, despite decades of trial and error, peripheral nerve injury is an impenetrable clinical dilemma. Any proven effective pharmacologic agent leads to a decisive leap forward to the clinical management of neuropathies. This study investigated the effects of tacrolimus and erythropoietin on sciatic nerve regeneration. Twenty-three mice were randomly assigned to tacrolimus, erythropoietin, tacrolimus + erythropoietin, control, and sham groups following sciatic nerve crush via hemostatic forceps. Medications were administered for 28 consecutive days. The sham group received neither crush injury nor medication. Histopathologic, immunohistochemical, and walking track analyses were performed. In the erythropoietin group, axonal swelling was significantly reduced and the average axonal number significantly recovered up to 75% of normal nerve compared to other groups. Marked immunoreactivity to GFAP and S-100 protein was present in the tacrolimus group. Nevertheless, at least moderate GFAP and S-100 expressions were observed in all of the groups. Functional recovery was superior in the tacrolimus group after 14 days, although a complete return to near-normal function was achieved in all groups after 28 days, regardless of the medication used. Our data supported the neurotrophic effects of tacrolimus and erythropoietin; however, not enough data was gathered to confirm their synergistic effects. Whether these results are extensible to clinical scenarios requires further detailed investigations.
Publisher
Walter de Gruyter GmbH
Subject
General Veterinary
Reference40 articles.
1. Jones, S., Eisenberg, H.M., Jia, X. (2016). Advances and future applications of augmented peripheral nerve regeneration. Int J Mol Sci. 17(9): 1494. https://doi.org/10.3390/ijms17091494 PMid:27618010 PMCid:PMC5037771 2. Panagopoulos, G.N., Megaloikonomos, P.D., Mavrogenis, A.F. (2017). The present and future for peripheral nerve regeneration. Orthopedics 40(1): e141-e156. https://doi.org/10.3928/01477447-20161019-01 3. Labroo, P., Ho, S., Sant, H., Shea, J., Gale, B.K., Agarwal, J. (2016). Controlled delivery of FK506 to improve nerve regeneration. Shock 46(3S): 154-159. https://doi.org/10.1097/SHK.0000000000000628 PMid:27058050 4. Caillaud, M., Chantemargue, B., Richard, L., Vignaud, L., Favreau, F., Faye, P.A., Vignoles, P.A., et al. (2018). Local low dose curcumin treatment improves functional recovery and remyelination in a rat model of sciatic nerve crush through inhibition of oxidative stress. Neuropharmacology 139, 98-116. https://doi.org/10.1016/j.neuropharm.2018.07.001 PMid:30018000 5. Chen, M.M., Qin, J., Chen, S.J., Yao, L.M., Zhang, L.U., Yin, Z.Q., Liao, H. (2017). Quercetin promotes motor and sensory function recovery following sciatic nerve-crush injury in C57BL/6J mice. J Nutr Biochem. 46, 57-67. https://doi.org/10.1016/j.jnutbio.2017.04.006 PMid:28458138
|
|